Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people [20]

Gut

Volumn 56, Issue 7, 2007, Pages 1034-1035

  John, Biku J ^a   Abulafi, Al Mutaz ^a   Poullis, Andrew ^a   Mendall, Michael Anthony ^a  

^a MAYDAY UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CHRONIC INFLAMMATION; COLORECTAL CANCER; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENTERITIS; HIGH FIBER DIET; HUMAN; LETTER; OBESITY; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR;

AGED; CHRONIC DISEASE; COLORECTAL NEOPLASMS; FECES; HUMANS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTE L1 ANTIGEN COMPLEX; MIDDLE AGED; OBESITY;

EID: 34347229116     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.125955     Document Type: Letter

References (11)

1. Frezza EE, Wachtel MS, Chiriva-Internati M. Influence of obesity on the risk of developing colon cancer. Gut 2006;55:285-91.
2. Hall NR. Survival in colorectal cancer: impact of body mass and exercise. Gut 2006;55:8-10.
3. Boland CR, Luciani MG, Gasche C, et al. Infection, inflammation, and gastrointestinal cancer. Gut 2005;54:1321-31.
4. Mendall MA, Strachan DP, Butland BK, et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 2000;21:1584-90.
5. Poullis A, Foster R, Shetty A, et al. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2004;13:279-84.
6. Clevers H. At the crossroads of inflammation and cancer. Cell 2004;118:671-4.
7. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-56.
8. Ghanim H, Aljada A, Hofmeyer D, et al. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004;110:1564-71.
9. Pavlov VA, Tracey KJ. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005;19:493-9.
10. Soderholm JD, Streutker C, Yang PC, et al. Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut 2004;53:1817-24.
11. Suenaert P, Bulteel V, Lemmens L, et al. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am J Gastroenterol 2002;97:2000-4.